Here's what city health systems are doing on recent Covid upswing and omicron variant
Arvin Dar, PhD, Ernesto Guccione, PhD, and Amaia Lujambio, PhD, researchers at The Tisch Cancer Institute at the Icahn School of Medicine, were awarded $3.15 million in grant funding from the National Cancer Institute to support research efforts that could lead to new treatments for hepatocellular carcinoma.